This reading list we received from Drs entirely disinterested. E. Valstar, (Orthomolecular) doctor / biologist. We provide this list are unchanged for publication. .
Scroll down for list.
Valstar wrote the book Nutritional intervention in cancer, a signal to the conventional oncology. See description on page, etc. ISBN cancer rates. We want to mention that we have no business or substantive ties with Engelbert Valstar, but this book and lists seem to us so interesting that we want to change places. Questions / comments can be sent to the editor: redactie@kanker-actueel.nl We will keep your questions / comments to be forwarded Valstar. Also on this list and further information on this page is of course our disclaimer applies.
More detailed descriptions and other studies see and nutrition research. And we try to at least the abstract and the results of the Phase III trials and pivotal Phase II studies in the literature list and nutrition research. or current mainstream research to publish or not fitted comments.
For regular treatments in general because the only randomized study possible side effects. Moreover, a randomized study of conventional treatments often never implemented. This assertion of Valstar based on relevant literature is in NTvG (see NTvG 136: 709-710, 1992) by the respective oncologists not contradicted.
See also Nutritional Oncology, Heber D. et al ISBN 0-12-335960-0, the book was edited by Harvard and by the Memorial Sloan Kettering Institute! ).
(Editors note: See extensive bibliography in the book of Valstar Nutritional intervention in cancer, a signal to the conventional oncology and now as published on this site)..
To this list are Hans Houtsmuller, Ed Woerlee Johan Bolhuis and important contributions.
Bibliography of studies cancer and nutrition / supplementation. Studies: 301 t / m 400
301) Okuno SH et al, Am J Clin Oncol 22: 258-61, 1999; In this randomized study in 66 patients decreased glutamine stomatitis associated with 5-FU is not detectable, the 14 studies on this list only as glutamine (an extra ) adjuvant, including the publication of 14 September fall significantly in favor of glutamine, an interim analysis is based on statistically more than expected by chance.
302) RG Wadleigh et al, Am J Med 92: 481-4, 1992; Vitamin E is in double-blind placebo-controlled study mucositis due to chemotherapy.
303) Unger C et al, Arzneimittelforschung 51: 332-8, 2001, an extract of E-Coli Bacteria reduces the effects of 5-FU in advanced colorectal cancer demonstrated, in the group with the E coli extract, the regression risk and survival is not significantly better than in the control group.
304) Salminen E et al, Clin Radiol 39: 435-7, 1988; Lactobacilli - (ed. note: lactic acid bacteria or probiotics sometimes called -) reduce diarrhea by radiotherapy in randomized studies.
305) H Ekert et al, Med Pediatr Oncol 8 :47-51, 1980, co-trimoxazole and lactobacilli found in comparison with other forms of selective bowel decontamination no nausea or vomiting it. Remarkably, all publications from this list on lactic acid bacteria or their extracts are beneficial (5,6,41,42,108,133,304 and 305).
306) Bogliun G et al, Ital J Neurol Sci 13: 643-7, 1992, Glutathione reduces randomized study the neurotoxicity of cisplatin.
307) K. Ohashi et al, Am J Hematol 64: 32-8, 2000, Veno-occlusive disease in the liver as a complication of stem cell is ursodeoxycholic acid in randomized studies in only 3.5% of cases (compared with 18, 5% of patients in the control group).
308) Ghosh S, Palmer KR, Gut 35: 1757-9, 1994, Ursodeoxycholic acid in patients with galgangcarcinoom shows that the biliary stent to keep open are unable to re-seal to prevent or slow down, and there was no effect on survival.
309) Griff Berg L et al, Gynecol Oncol 66: 417-24, 1997; Constipation is often a major problem after radical hysterectomy due to uterine cancer, a high fiber diet that appears as expected in randomized studies largely counter.
310) Cangiano C et al, JNCI 88: 14 grams of branched-chain amino acids per day, resulted in a randomized double-blind study of 28 cancer patients the onset of cachexia significantly combat, this effect was correlated with a higher caloric intake induced by the BCAA .
311) The San-In Group of Liver Surgery, Br J Surg 84: 1525-1531, 1997; Pharmacological amounts of BCAAs promote liver recovery after partial liver resection due to primary liver cancer, after a long period may not affect recurrence or overall survival.
312) Mix WC et al, Aust NZJ Surg 69: 811-5, 1999; BCAA in high doses improves liver function after partial resection because of primary liver cancer so quickly that arguably shortened the length of stay.
313) Daly JM et al, Am J Surg 153: 198-206, 1987; High doses of BCAA after jejunostomy are associated with cancer a faster return to oral feeding possible.314) Wattel E et al, Br J Haematol 102: 1015-1024, 1998; case of MDS with a P-glycoprotein appears to be potentiated chemotherapy by quinine. In this study, half of P-glycoprotein such. Nevertheless, there were more regressions in the quinine group and it had a better survival than the control group. See studieno. 272, this study showed a similar result.
315) St Fan et al, N Engl J Med 331: 1547-1552, 1994; BBCA reduction in partial hepatectomy for a primary liver cancer, cirrhosis which often is involved in randomized studies significant complications.
316) V Liguori et al, Radiother Oncol 42: 155-61, 1997; cream with hyaluronic acid reduces randomized double-blind studies skin damage associated with radiation.
317) Solary E et al, Blood, March 27, 2003, in acute myeloid leukemia quinine enhances the response to a positive probability only rhodamine-efflux (Glycoproteine-P!), the survival is Quinine now does not improve, which unlike in MDS : see studieno. 272 and 314.
318) Solary et al, Blood 88: 1198-205, 1996, Quinine used for acute leukemia (myeloid and lymphoid) and myeloproliferatief syndrome increases the risk of response to chemotherapy is not significant, the difference was greater in favor of quinine in cases of a positive P-glycoprotein, but this was not significant, the persistence of blasts and / or an increase in incidence, however, was lower in the quinine group, it was in the kininegroep toxicity was enlarged, a combined analysis of 317 and 318 would be useful.
319) R Jyothirmayi et al, Eur J Cancer B Oral Oncol 32B: 373-6, 1996, Vitamin A in a randomized trial at a dose of 200,000 IU per week randomized study was unable fewer relapses plus new cancers to decrease . Given other studies in humans (1050000 IU per week!) And especially compared to animal studies, the low dose used. Vitamin A related study numbers are 14.15 and 109 significantly in favor of vitamin A from, although only two of these also showed life extension, Study Numbers 47,129,267 and 319 have no significant effect of vitamin A to see. It must be noted again, the metabolites of beta-carotene and vitamin A are more successful, they will be weighed separately later.
320) Cascinu S et al, J Clin Oncol 20: 3478-83, 2002, Glutathione reduces the neurotoxicity of carboplatin significantly, the number of regressions in the glutathione group was not significantly greater.
321) Porsche R et al, J Clin Oncol 19: 1787-1794, 2001, 5-FU plus leucovorin improves in cancer patients with stage C colon cancer, after surgery the cure rate significantly more than 5-FU plus levamisole.
322) Hunter E et al, J Clin Oncol 14: 2274-9, 1996, 50 mg of leucovorin per square meter of body surface per week improves the functioning of 5-FU in cancer patients with metastases only with no more than 20 mg.
323) Kohne CH et al, J Clin Oncol 16: 418-26, 1998; leucovorin adjuvant is a better addition to 5-FU than interferon in cases of metastatic cancer, both progression-free survival period was leucovorin seconds better.
324) Lissoni P et al, J Pineal Res 30: 123-6, 2001; methoxytryptamine plus melatonin in cancer patients show an insufficient number of platelets compared with melatonin alone to normalize.
325) A. Burgos et al, Lymphology 32: 3-10, 1999; Coumarin reduces randomized study lymphedema in breast cancer patients, which is a consequence of surgery and radiation.
326) Pecking A, J Mal Vasc 15: 157-8, 1990; Coumarin decreased in this randomized double-blind study lymphedema in breast cancer patients.
327) Federico A et al, Eur J Clin Nutr 55: 293-7, 2001, cancer patients who received chemo selenium and zinc were less affected by an increased appetite and asthenia than patients who have chemotherapy, but not selenium and zinc were .
328) Lyman GH et al, N Engl J Med 302: 257-60, 1980; Lithium reduces leukopenia during chemotherapy in small cell lung cancer (45 patients total), so that fewer infections occur more intensive chemotherapy and detection is possible, the number deaths from infections was significantly reduced in the litiumgroep.
329) Creagan ET et al, N Engl J Med 301: 687-90; Vitamin C as ascorbic acid prolongs the life of cancer patients compared to placebo, no, see also 49, in other tumors and / or other combinations of agents like vitamin C or of interest in metastatic colorectal cancer is the only additional supplement in any case not meaningful.
330) PG Steinherz et al, J Pediatr 96: 923-7, 1980, Lithium is leukopenia in patients who receive chemotherapy significantly against, in the lithium group was also involved in fewer infections, although the difference is not significant.
331) Lyman GH et al, Am J Med 70: 1222-9, 1981, patients with small cell lung cancer who receive chemotherapy have less problems with lithium ditto leukopenia and fewer infections and less time spent in hospital, the lithium group also received significantly more chemotherapy (could significantly longer receive chemotherapy); those lithium ever by obtained had a higher response probability and a longer survival, because some patients with lithium stopped, the survival of the lithium group but not significantly better than the control group.
332) Pace A et al, J Clin Oncol 21: 927-31, 2003, Vitamin E prevents the neurotoxicity of cisplatin significantly. Ed. Note: Abstract is under study and nutrition research published.
333) Lahousse M et al, Wien Klin Wochenschr 96: 739-41, 1984; Lithium reduced in this small randomized study demonstrated leucopenia.
334) Lyman GH et al, J Clin Oncol 2: 1270-6, 1984, Lithium reduces leukopenia in patients with small cell lung cancer who receive chemotherapy, pre-existing cardiac disease and / or use of bronchusdlatatoren However, a contra-indication (by a lower leukopenia, more chemotherapy given, which in this case means more adriamycin and therefore less good for the heart).
335) Horns RC et al, Med Pediatr Oncol 12: 169-72, 1984; In this small trial (35 patients with acute myeloid leukemia) showed no evidence of leukopenia lithium counter, an overall analysis (328,330, 331, 333, 334 and 335) shows that lithium leukopenia by chemotherapy to go, it is clear that this is a pre-existing cardiac disease and / or use of brochusdlatatoren in case of including adriamycin pointless, were studied so does the risk of infection and mortality result by lithium off.
336) Yan Y, Zhongguo Zhong Xi Yi Jie He Za Zhi 15: 643-5, 1995, Traditional Chinese medicine increases the chance of remission in patients with acute leukemia and improves their survival.
337) Shao ZX et al, Zhongguo Zhong Xi Yi Jie He Za Zhi 21: 168-70, 2001; Gan'ai 1 and 2 chemoembolisatie improve the outcome of patients with primary liver cancer, these herbs stimulated significantly the risk of regression and improved survival significantly.
338) Wang Q et al, Zhongguo Zhong Xi Yi Jie He Za Zhi 18: 662-4, 1998, Chinese herbs were in patients' head and neck cancer, receiving radiotherapy, significant dryness of the mouth from the salivary glands to radiation protection.
339) Wang C et al, Zhongguo Zhong Yi Jie He Za Zhi X 19 :389-91, 1999, Chinese herbs reduce diarrhea and mucositis associated with rectal infusion of 5-FU for rectal cancer.
340) Xie FY et al, Zhongguo Yi Jie He Za Zhi X 21: 888-90, 2001, Antike improves the results of radiation to treat the nasopharynxcarcinoom, there was significantly less radiation needed to achieve a complete response, though ultimately The complete response 'rate' in the group antike not significantly higher than in the control group.
341) Martin-Jimenez M et al, N Engl J Med 315: 894-5, 1986; Vitamin E in randomized studies will not stop hair loss by adriamycin.
342) Petrioli R et al, Eur J Cancer 31A: 2105-8, 1995, folinic acid improves response likely next 5-FU in patients with metastatic colorectal cancer, the median survival was significantly improved by folic acid.
343) QS Li et al, Chin Med J (Engl) 107: 289-94, 1994, double-blind study in Chinese herbs reduce postoperative pain in cancer patients, these herbs also reduce constipation (by stimulation of peristalsis) and urinary retention after surgery.
344) Murphy J et al, Can Oncol Nurs J 10: 96-100, 2000, psyllium husks are good randomized trial in diarrhea associated with pelvic radiotherapy significantly against.
345) Barrington JW et al, Br J Urol 78: 54-6, 1996, after cystectomy due to bladder cancer Pentosanpolysulfaat reduce tissue growth in and mucusproductie (gut)-artificial bladder, resulting in significantly reduced symptoms.
346) Slesarev VI et al, Med Oncol 15: 37-43, 1998, in patients in advanced stages of cancer and prone to the toxicity of TNF, was the condition of D-peptidoglucaan significantly improve.
347) Dale PS et al, Cancer Chemother Pharmacol 47 Suppl: S29-34, 2001, the combination of trypsin, chymotrypsin and papain significantly reduces the side effects of radiotherapy in cases of cervical cancer (2a / m 3b).
348) MS Gujral et al ", Cancer Chemother Pharmacol 47 Suppl: S23-8, 2001, Proteolytic enzymes significantly decrease the side effects of radiotherapy for throat cancer patients.
349) Korpan MI and Fialka V. Wien Med Wochenschr 146: 67-72, 1996, Wobenzym reduces arm lymphedema in breast cancer patients demonstrated better than diuretics.
350) Martin T et al, Radiother Oncol 65: 17-22, 2002, the combination of trypsin, chymotrypsin and papain do not improve the effects of radiation therapy used as adjuvant after surgery for cancer in the pelvic area. Combination of studies 350 347 and 348 leads, however, came to the conclusion that these enzymes are useful in addition to the radiation side-effects.
351) Bjornsson S et al, Cancer Treatment Rep. 62: 505-10, 1978; Corynebacterium parvum enhances the survival of lung cancer patients, stage 3, BCG does not in this study.
352) Pinto A et al, Dis Colon Rectum 42: 788-95, 1999, Short-chain fatty acids promote healing bestralingsproctitis compared to placebo.
353) O'Brien ME et al, Br J Cancer 83: 853-7, 2000, an extract of gedodeMycobacterium vaccae improves survival in randomized studies of patients with non-small cell lung cancer or a mesothelioma that chemo / radiation will, too sleep and appetite were Mycobacterium vaccae group better.
354) Woodruff M and Walbaum P, Cancer Immunol Immunother 16: 114-6, 1983; In 49 patients with operable lung cancer was Corynebacterium parvum in a vaccine form is injected, the Corynebacterium parvumgroep there was a trend toward longer life, the mortality from squamous carcinoma of the lung was also demonstrated in Corynebacterium parvumgroep lower.
355) GP Sarna et al, Cancer Treat Rep 62: 681-7, 1978; bronchuscarcinoompatiënten Seventy-nine were randomized based on chemo Corynebacterium parvum and BCG vaccine or not. Immunotherapy was the response probability and the time to further progression of the disease to affect.
356) The Ludwig Lung Cancer Study Group, Cancer Immunol Immunother 23: 1-4, 1986, this double-blind study in 286 patients with NSCLC stage 1 or 2, Corynebacterium parvum produced no demonstrable benefit with regard to disease-free survival and survival seconds, a combined analysis of 351, 354, 355 and 356 is recommended, it seems now, however, that extracts of Corynebacterium parvum in the treatment of lung cancer on only certain subgroups may be useful.
357) Chisesi T et al, J Biol Regul Homeost Agents 2: 193-8; Thymushormoon charged with Hodgkin's disease in patients with chemo / radiotherapy to treat immunosuppression related to it and the risk of herpes infections (ranging from 54% to 18%).
358) Braga M et al, Br J Surg 81: 205-8, 1994; Thymopentine reduced in elderly patients due to gastro-intestinal cancer surgery, the risk of immunosuppression associated with operating and ditto the risk of sepsis.
359) Tallman MS et al, New Engl J Med 337: 1021-8, 1997, all-trans retinoic acid (a vitamin A-like substance!) Improves both the induction phase and after the disease-free survival and survival sec in patients with acute promyelocytic leukemia.
360) Bellantone R et al Sure Gery 132, 1109-12, 2002, after total calcium and vitamin D reduce thyreodectomie randomized study the symptoms of hypocalcemia.
361) Hong WK et al, N Engl J Med 323: 795-801, 1990, 13-cis-retinoic acid does not reduce the risk of recurrence of throat cancer, but the risk of new primary cancer of the throat (actually a case of early therapeutic effect).
362) Fenaux P et al, Leukemia 8 Suppl 2: S42-7, 1994, All-transretinoinezuur (ATRA) reduces the risk of a randomized study of recurrent promyelocytic leukemia.
363) Fenaux P et al, Leukemia 14: 1371-7, 2000, Atra improves disease-free survival and survival of patients with promyelocytic leukemia seconds.
364) Fenaux P et al, Blood 94: 1192-200, 1999, ATRA improves disease-free survival and survival in patients with promyelocytic leukemia seconds.
365) Fenaux P et al, Blood 82: 3241-9, 1993; ATRA improves relapse-free-survival of patients with acute promyelocytic leukemia.
366) Belbabri A et al A et al, Hematol J 3: 49-55, 2002; ATRAis (chemo) in a relapsed or primary refractory acute promyelocytic leukemia unable to improve prognosis, ATRA is useful for first / maintenance therapy; in the category of patients in this study seems ATRA does not make sense.
367) Walmsley S et al, J Acquire Immune Defic Syndr 22: 235-46, 1999: 9-cis-retinoic acid (another metabolite) shows randomized double-blind study locally applicated effective against Kaposi's sarcoma ie 9-cis-retinoic acid was on 50% of patients responded.
368) Bodsworth NJ et al, Am J Clin Dermatol 2: 77-87, 2001, this study in terms of questions and results comparable to reference 367.
369) Nayel H et al, Nutrition 8: 13-8; Protein Supplementation on irradiation is due to throat cancer weight loss, more relevant to the radiation also significantly more likely to be continued.
370) D Fritze et al, Klin Wochenschr 60: 593-8, 1982, Corynebacterium parvum (subcutaneously on day 1 of chemotherapy) blijktin a randomized trial in patients with breast cancer who received chemotherapy remission duration and survival is not significantly improve, although it was so that patients in the single vaccination with ulceration responded arguably much longer lived.
371) D Fritze et al, Klin Wochenschr 62: 162-7, 1984; Subcutaneous administration of Corynebacterium parvumpreparaat (on day 1 or day 14 in addition to chemotherapy) shows an equal probability of response to give as an intravenous Corynebacterium parvumextract, subcutaneous administration show the responders, however, very significantly much longer to live.
372) Heiny BM, Krebsmedizin 12: 3-14, 1991; Mistletoe decreases in breast cancer patients who receive chemotherapy leukopenia and improves the detection quality of life.
373) Fisher B et al Cancer 66: 220-7, 1990; In this randomized study shows a Corynebacterium parvum extract as additional adjuvant chemo given to basically curative breast cancer patients with positive axillary nodes, the prognosis is not improving. Combination of 370,371 and 373 lead me in breast cancer Corynebacterium parvum not currently recommended as standard.
374) Ibrahim EH et al, J Urol 140: 498-500, 1988; Maltosetetrapalmitaat as local drug after resection of superficial bladder tumors, the recurrence risk appears to decrease approximately as much as BCG.
375) Schulof RS et al, J Biol Resp MOD 4: 147-58, 1985, synthetic thymosin alpha-1 vermindertbij patients with non small cell lung cancer with chemo / radiation treatment and immunosuppression improves disease-free survival and survival sec.
376) Ochiai T et al, Cancer Immunol Immunother 14: 167-71, 1983; BCG extract improves survival in randomized studies of gastric cancer patients following surgery and get adjuvantchemo.
377) Wolmark N et al, JNCI 80: 30-6, 1988, in patients with colon cancer stage B or C with BCG in a randomized study of the overall decline in mortality found.
378) Vermorken JB et al, Lancet 353: 345-50, 1999, a vaccine plus BCG own tumor cells appears as an adjuvant in cancer patients, stage 2 and 3 are appropriate, disease-free survival after a median 5.3 years was better with the vaccine, subgroup analysis indicated that the benefit came just two stages, there was also a trend towards improved survival in the vaccine group.
379) Herr HW et al, J Clin Oncol 13: 1404-8, 1995; BCGvermindert the risk of recurrence in patients with bladder cancer are due to a local surgery.
380) Lamm DL et al, J Urol 163: 1124-9, 2000, BCG reduces the risk of recurrence of bladder cancer after local operations considerably.
381) Kolodziej A et al, BJU Int 89: 620-2, 2002; In this BCG study shows the risk of recurrence in bladder cancer patients after operation to reduce significantly, there are many more besides these three studies, it is important that local BCG itt chemotherapy (also locally less effectively) a reduction in mortality was demonstrated (see Lamm DL, Eur Urol 37 Suppl 1: 9-15, 2000). BCG thus deserves more status in the treatment of bladder cancer.
382) A. Lipton et al, Cancer 51: 57-60, 1983, Corynebacterium parvum as adjuvant reduces the risk of recurrence in melanoma patients stage 2, not stage 1, BCG was found in this study no effect on the recurrence chance.
383) A. Lipton et al, J Clin Oncol, 9: 1151-6, 1991; Corynebacterium parvumextract improves with stage 2 melanoma patients were disease-free survival and survival sec.
384) Thatcher N et al, Br J Surg 73: 111-5, 1986; Corynebacterium parvum extract as an adjuvant for patients operated on due to a stage 2 melanoma is associated with a significantly lower probability of response to DTIC plus actinomycin D, while delivering a nonsignificant improved (disease free) survival. Combination of 382, 383 and 384 leads me to the preliminary conclusion that Corynebacetrium parvumextract disease-free survival for patients operated for a stage 2 melanoma increases, a reduction in mortality by Corynebacterium parvum in stage 2 there are also insufficient evidence.
385) WHO Collaborating Centres for Evaluation of Methods of Diagnosis and Treatment of Melanoma, Treatment of Tumors 70: 41-8, 1984; patients with metastatic melanoma who DTIC (carboxamide) will neither benefit from BCG or after vaccination with Corynebacterium parvum: the response probability and survival are not improved with non-specific immunotherapy, although nonspecific immune stimulation, responses occurred by demonstrably faster, though that under these conditions is insufficient clinical significance. Further research is needed.
386) Clark RE et al, Lancet i: 763-5, 1987; In a clear pre-defined subgroup of patients with myelodysplastic syndrome decreased 13-cisretinoinezuur mortality.
387) Koeffler HP et al, Blood 71: 703-8, 1988, in patients with myelodysplastic syndrome showed a 13-cisretinoinezuur in this study had no effect on any progression of the disease, the duration of the study was 6 months, to The final parameter is much harder survival was not examined or could not be examined, which had been in a protracted supplementation should.
388) Ravaud A et al, J Clin Oncol 8: 608-14, 1990; BCG provides for NHL patients with poor prognosis and additional treatment for complete responders to chemotherapy improves disease-free survival and survival sec, BCG remains after multivariate analysis as a significant factor intact.
389) hoerni B et al, Oncology 39: 292-5, 1982.
BCG appears in a small randomized trial alongside chemotherapy and radiotherapy to improve disease-free survival.
390) hoerni B et al, Br J Haematol 42: 507-14, 1979, in a randomized trial in NHL patients with a lower forecast showed both BCG disease-free survival and survival improvement seconds.
Hoerni B et al, Br J Hematol 71: 161-3, with longer follow-up reference 390 indicates that the survival BCG seconds after over 11 years is much better: just 60 instead of 30%.
391) hoerni B et al, Recent Res Cancer Res 80: 92-7, 1982, BCG appears in patients with NHL, just in a complete remission of the disease-free survival to improve the survival seconds was just not significantly better.
392) Thomas JW et al, Can Med Assoc J 129: 439-42, 1983; BCG as maintenance therapy after complete remission improves in NHL patients randomized study of life expectancy.
393) hoerni B et al, Recent Res Canc Res 65: 160-3, 1978; BCG improves in patients with NHL, in whom chemotherapy and radiation with a complete remission was achieved disease-free survival in limited follow-up is not significant; 388 t / m 393 delivers a totally ruthless conclusion that BCG after complete remission in NHL patients improves disease-free survival, a further analysis would be more able to deliver.
394) MJ O'Connell et al: Int J Oncol Biol Phys Radiate 8: 1115-9, 1982, in addition to radiotherapy for inoperable BCG colorectal cancer improves progression-free survival period and not sec; seen reference to a lesser extent 378 and 377, one would BCG with killed cancer cells in a adjuvantsetting should try.
395) Senkal M et al, Crit Care Med 25: 1489-1496, 1997; The combination of omega-3 fatty acids, arginine and RNA, to complement the food, reduces randomized double-blind study in patients operated on because of a gastrointestinal malignancy, the risk late postoperative complications and reduce total treatment costs by more than 30%.
396) Braga M et al, Surgery 132: 805-14, 2002, Omega-3 fatty acids plus arginine and oral supplementation from 5 days before colorectal surgery reduces the number of postoperative infections.
397) Braga M et al, Arch Surg 137: 174-80, 2002, Omega-3 fatty acids, arginine and RNA makes the number of postoperative complications in relatively malnourished patients who need surgery for a malignancy of the gastrointestinal tract reduced and shortened their hospital stay.
398) Gianotti L et al, Arch Surg 132: 1222-9, 1997, Omega-3 fatty acids, arginine and RNA reduction in patients with gastric or pancreatic surgery for cancer, the risk of infection and shorten hospitalization.
399) Di Carlo V et al, Dig Surg 16: 320-6, 1999, Omega-3 fatty acids, arginine and RNA reduction in patients with pancreatic cancer surgery because the risk of infection, the severity of infections and length of stay in hospital.
400) Braga M et al, Crit Care Med 26: 24-30, 1998, Omega-3 fatty acids, arginine and RNA impaired in patients due to gastric or pancreatic cancer need surgery, the risk of infection, the severity of the infection and the length of stay in hospital.
For further study see this link.
